Related Experiment Video
Updated: Mar 10, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor α-mediated neurotoxicity
Dong Hwan Ho1, Wongi Seol1, Jin Hwan Eun2
1InAm Neuroscience Research Center, Sanbon Medical Center, Collage of Medicine, Wonkwang University, 321 Sanbon-ro, Gunposhi, Gyeonggido, Republic of Korea.
Abstract:
Leucine-rich repeat kinase (LRRK2), a major causal gene of Parkinson's disease (PD), functions as a kinase. The most prevalent mutation of LRRK2 is G2019S. It exhibits increased kinase activity compared to the wildtype LRRK2. Previous studies have shown that LRRK2 can phosphorylate p53 at T304 and T377 of threonine-X-arginine (TXR) motif in neurons. Reduction of LRRK2 expression or inhibition of LRRK2 kinase activity has been shown to be able to alleviate LPS-induced neuroinflammation in microglia cells. In this study, we found that LRRK2 could also phosphorylate p53 in microglia model BV2 cells. Transfection of BV2 with phosphomimetic p53 T304/377D significantly increased the secretion of pro-inflammatory cytokine TNFα compared to BV2 transfected with p53 wild type after LPS treatment. In addition, conditioned media from these transfected cells increased the death of dopaminergic neuronal SN4741 cells. Moreover, such neurotoxic effect was rescued by co-treatment with the conditioned media and etanercept, a TNFα blocking antibody. Furthermore, TNFα secretion was significantly increased in primary microglia derived from G2019S transgenic mice treated with LPS compared to that in cells derived from their littermates. These results suggest that LRRK2 kinase activity in microglia can contribute to neuroinflammation in PD via phosphorylating p53 at T304 and T377 site.
Insights
Leucine-rich repeat kinase (LRRK2) activity in microglia drives Parkinson's disease neuroinflammation. LRRK2 phosphorylates p53, increasing TNFα and dopaminergic neuron death.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Leucine-rich repeat kinase (LRRK2) is a key gene in Parkinson's disease (PD).
- The G2019S mutation increases LRRK2 kinase activity.
- LRRK2 phosphorylates p53 in neurons; its inhibition reduces neuroinflammation in microglia.
Purpose of the Study:
- To investigate LRRK2's role in microglia-mediated neuroinflammation in Parkinson's disease.
- To determine if LRRK2 phosphorylates p53 in microglia.
- To assess the impact of LRRK2-mediated p53 phosphorylation on pro-inflammatory cytokine secretion and neuronal survival.
Main Methods:
- Utilized BV2 microglia cell line and primary microglia from G2019S transgenic mice.
- Transfected BV2 cells with wild-type and phosphomimetic p53 (T304/377D).
- Treated cells with lipopolysaccharide (LPS) and assessed TNFα secretion, conditioned media neurotoxicity, and rescue with etanercept.
Main Results:
- LRRK2 phosphorylates p53 in BV2 microglia.
- Phosphomimetic p53 (T304/377D) significantly increased LPS-induced TNFα secretion.
- Conditioned media from transfected cells induced dopaminergic neuron death, which was rescued by etanercept.
- Primary microglia from G2019S mice showed increased TNFα secretion upon LPS treatment.
Conclusions:
- LRRK2 kinase activity in microglia contributes to Parkinson's disease neuroinflammation.
- Phosphorylation of p53 at T304/T377 by LRRK2 is a mechanism driving this neuroinflammation.
- Targeting LRRK2 or TNFα may offer therapeutic strategies for Parkinson's disease.
More Related Videos
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
mTOR Signaling and Cancer Progression
The mTOR pathway or the...